Literature DB >> 23892446

Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision.

Amit Noheria, Samuel J Asirvatham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23892446     DOI： 10.1007/s10840-013-9821-7

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  24 in total

1.  Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

Authors:  S E Coplen; E M Antman; J A Berlin; P Hewitt; T C Chalmers
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

2.  Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging.

Authors:  Thomas Deneke; Dong-In Shin; Osman Balta; Kathrin Bünz; Frank Fassbender; Andreas Mügge; Helge Anders; Marc Horlitz; Markus Päsler; Sinthu Karthikapallil; Thomas Arentz; Dieter Beyer; Martin Bansmann
Journal:  Heart Rhythm       Date:  2011-07-02       Impact factor: 6.343

3.  Signals.

Authors:  Malini Madhavan; Shalini R Govil; Samuel J Asirvatham
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-02

Review 4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

5.  Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.

Authors:  Rangadham Nagarakanti; Michael D Ezekowitz; Jonas Oldgren; Sean Yang; Michael Chernick; Timothy H Aikens; Greg Flaker; Josep Brugada; Gabriel Kamensky; Amit Parekh; Paul A Reilly; Salim Yusuf; Stuart J Connolly
Journal:  Circulation       Date:  2011-01-03       Impact factor: 29.690

6.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

7.  Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.

Authors:  Daniel W Kaiser; Megan M Streur; Rangadham Nagarakanti; S Patrick Whalen; Christopher R Ellis
Journal:  J Interv Card Electrophysiol       Date:  2013-04-28       Impact factor: 1.900

8.  Concurrent application of charge using a novel circuit prevents heat-related coagulum formation during radiofrequency ablation.

Authors:  Bernard Lim; Kalpathi L Venkatachalam; Arshad Jahangir; Susan B Johnson; Samuel J Asirvatham
Journal:  J Cardiovasc Electrophysiol       Date:  2008-03-21

9.  Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Mohamed Bassiouny; Walid Saliba; John Rickard; Mingyuan Shao; Albert Sey; Mariam Diab; David O Martin; Ayman Hussein; Maurice Khoury; Bernard Abi-Saleh; Samir Alam; Jay Sengupta; P Peter Borek; Bryan Baranowski; Mark Niebauer; Thomas Callahan; Niraj Varma; Mina Chung; Patrick J Tchou; Mohamed Kanj; Thomas Dresing; Bruce D Lindsay; Oussama Wazni
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-04-03

10.  Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.

Authors:  William Maddox; G Neal Kay; Takumi Yamada; Jose Osorio; Harish Doppalapudi; Vance J Plumb; Alicia Gunter; H Thomas McElderry
Journal:  J Cardiovasc Electrophysiol       Date:  2013-04-11
View more
  2 in total

Review 1.  Atrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.

Authors:  Christopher V DeSimone; Elisa Madhavan; Sébastien Ebrille; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 2.  Atrial Fibrillation and Stroke: Increasing Stroke Risk with Intervention.

Authors:  Christopher V DeSimone; Malini Madhavan; Elisa Ebrille; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  Card Electrophysiol Clin       Date:  2014-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.